Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB1 receptor antagonist

J. L. Wiley, C. S. Breivogel, A. Mahadevan, R. G. Pertwee, M. G. Cascio, D. Bolognini, J. W. Huffman, D. M. Walentiny, R. E. Vann, R. K. Razdan, B. R. Martin

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalEuropean Journal of Pharmacology
Volume651
DOIs
StatePublished - Jan 1 2011

Disciplines

  • Pharmacy and Pharmaceutical Sciences

Cite this